New eye drop aims to ease dry eye symptoms and boost work productivity
NCT ID NCT07266948
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a drug called TRYPTYR (Acoltremon) can improve quality of life and work ability in adults with chronic dry eye disease. About 40 participants who are unhappy with their current treatment will use the eye drops for one month. Researchers will measure changes in quality-of-life scores and symptom relief.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Acoltremon (TRYPTYR)
What this could lead to
If it works, this could offer a new option for people with dry eye disease whose current treatment isn't helping enough, potentially improving daily comfort and work performance.
What could go wrong
This is a small, short-term study (40 people, 1 month) with no placebo group, so results may not be reliable or apply to everyone. The drug may not work better than existing treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Complete Eye Care of Medina
RECRUITINGMedina, Minnesota, 55340, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Kannar Eye Care
RECRUITINGPittsburg, Kansas, 66762, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Southern College of Optometry
RECRUITINGMemphis, Tennessee, 38104, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••